Abbott and Zydus Cadila enter alliance for emerging markets
This article was originally published in Scrip
Executive Summary
Abbott Laboratories and Zydus Cadila have joined the expanding list of innovator-generic combines that are forming symbiotic relationships to tap into emerging markets, seen as the engine of future growth for the pharmaceutical industry.